Exact Mass: 962.5663

Exact Mass Matches: 962.5663

Found 7 metabolites which its exact mass value is equals to given mass value 962.5663, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Polymyxin B nonapeptide

2-Amino-N-(3-amino-1-{[6,9,18-tris(2-aminoethyl)-15-benzyl-2,5,8,11,14,17,20-heptahydroxy-3-(1-hydroxyethyl)-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaen-21-yl]-C-hydroxycarbonimidoyl}propyl)-3-hydroxybutanimidate

C43H74N14O11 (962.5661)

Apramide B

C51H78N8O8S (962.5663)

H-DL-xiThr-DL-Dab-DL-Dab(1)-DL-Dab-DL-Phe-DL-Leu-DL-Dab-DL-Dab-DL-xiThr-(1)

C43H74N14O11 (962.5661)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D011113 - Polymyxins D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D003879 - Dermatologic Agents Polymyxin B nonapeptide is a cyclic peptide obtained from Polymyxin B by proteolytic removal of its terminal amino acyl residue. Polymyxin B nonapeptide is less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes[1][2][3].

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C56H83O11P (962.5673)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C56H83O11P (962.5673)

n-[1-({1-[2-({1-[(1-{[2-(4-methoxyphenyl)-1-[methyl(1,3-thiazol-2-ylmethyl)carbamoyl]ethyl](methyl)carbamoyl}-2-methylpropyl)(methyl)carbamoyl]-2-methylpropyl}(methyl)carbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}(methyl)carbamoyl)ethyl]-n-methyloct-7-ynamide

n-[1-({1-[2-({1-[(1-{[2-(4-methoxyphenyl)-1-[methyl(1,3-thiazol-2-ylmethyl)carbamoyl]ethyl](methyl)carbamoyl}-2-methylpropyl)(methyl)carbamoyl]-2-methylpropyl}(methyl)carbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}(methyl)carbamoyl)ethyl]-n-methyloct-7-ynamide

C51H78N8O8S (962.5663)

n-[(1s)-1-{[(2s)-1-[(2s)-2-{[(1s)-1-{[(1s)-1-{[(1s)-2-(4-methoxyphenyl)-1-[methyl(1,3-thiazol-2-ylmethyl)carbamoyl]ethyl](methyl)carbamoyl}-2-methylpropyl](methyl)carbamoyl}-2-methylpropyl](methyl)carbamoyl}pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}ethyl]-n-methyloct-7-ynamide

n-[(1s)-1-{[(2s)-1-[(2s)-2-{[(1s)-1-{[(1s)-1-{[(1s)-2-(4-methoxyphenyl)-1-[methyl(1,3-thiazol-2-ylmethyl)carbamoyl]ethyl](methyl)carbamoyl}-2-methylpropyl](methyl)carbamoyl}-2-methylpropyl](methyl)carbamoyl}pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}ethyl]-n-methyloct-7-ynamide

C51H78N8O8S (962.5663)